Qiong Wu, Yuxiang Liu, Qingqing Chen and Xiaoyi Zhuang of Haiwen & Partners provide essential insights into an essential new judicial interpretation concerning labor dispute cases, including a comparison with the current rules and judicial practice and implications for compliance and risk management practices
Features & Analyses
- August 27, 2025
Eric (Ye) Zou of Merits & Tree Law Offices gives an overview of the core elements and key significance of a new pilot scheme which maps out a new way for foreign investors to access China’s flourishing financial markets
August 19, 2025In the first part of a series of articles, Jianwei (Jerry) Fang, Ke Dong, and Haoyi Sun of Zhong Lun Law Firm outline the general jurisdiction rules governing foreign-related civil litigation in China under the 2024 Civil Procedure Law, and explain the statutory framework, key jurisdictional bases, and procedural considerations that foreign companies and in-house counsel need to understand when facing potential lawsuits in Chinese courts
August 12, 2025Wei Huang, managing partner, and Kexin Chen, associate, at Beijing Tian Yuan Law Firm provide a comprehensive interpretation of a core provision of China’s revised Anti-Unfair Competition Law and its impact on enterprises of all sizes
August 01, 2025Daisy Duan, Xiaohong Chen, Cuishi Li of KWM examine a new tax credit policy which is aimed at boosting profit reinvestment by foreign investors
July 22, 2025A leading international healthcare General Counsel in the region provides an exclusive in-house perspective on the current law and practice of cross-border data transfer in China
July 15, 2025Casper Sek of Jingtian & Gongcheng examines new guidance from TC260 which looks likely to become an essential component in companies’ personal information protection toolkits
July 07, 2025The intersection between intellectual property and artificial intelligence raises challenging and significant legal issues. Danlei Wu of Fangda Partners examines China’s first case relating to the structure and parameters of an AI model
June 30, 2025CEO and General Counsel of MyoMed Bio, explains how legal strategy—spanning IP, regulatory compliance, and cross-border structuring—is essential for enabling clinical development, managing geopolitical and data protection risks, and aligning biotech operations across China, the U.S., and Australia.
June 17, 2025Xiangxiang Ma, a partner of Anjie Broad Law Firm, explores the various ways in which a recent U.S. executive order on drug pricing is impacting Chinese pharmaceutical companies’ license-out model
June 06, 2025










